Hybrid Intelligence Applied to Professional Pharmaceutical Healthcare Services: Enhancing Human Intelligence with Advanced Technologies
DOI:
https://doi.org/10.30827/ars.v66i2.33007Downloads
References
Foro de Atención Farmacéutica-Farmacia Comunitaria (Foro AF-FC), panel de expertos. Guía práctica para los Servicios Profesionales Farmacéuticos Asistenciales desde la Farmacia Comunitaria. Madrid: Consejo General de Colegios Oficiales de Farmacéuticos; 2024. Disponible en: https://www.farmaceuticos.com/wp-content/uploads/2021/02/2021-guia-practica-spfa.pdf.
Amariles P, Sabater-Hernández D, García-Jiménez E, et al. Effectiveness of Dader Method for pharmaceutical care on control of blood pressure and total cholesterol in outpatients with cardiovascular disease or cardiovascular risk: EMDADER-CV randomized controlled trial. J Manag Care Pharm. 2012;18(4):311-23. doi: 10.18553/jmcp.2012.18.4.311. DOI: https://doi.org/10.18553/jmcp.2012.18.4.311
Salazar-Ospina A, Amariles P, Hincapié-García JA, et al. Effectiveness of the Dader Method for Pharmaceutical Care on Patients with Bipolar I Disorder: Results from the EMDADER-TAB Study. J Manag Care Spec Pharm. 2017;23(1):74-84. doi: 10.18553/jmcp.2017.23.1.74 DOI: https://doi.org/10.18553/jmcp.2017.23.1.74
Monsalve-David M, Hincapié-García JA, Salazar-Ospina A, et al. Coste-efectividad del seguimiento farmacoterapéutico en pacientes con trastorno afectivo bipolar-I: ensayo clínico aleatorizado EMDADER-TAB. PharmacoEcon Span Res Artic. 2017;14:31-38. doi: 10.1007/s40277-017-0068-z. DOI: https://doi.org/10.1007/s40277-017-0068-z
Niazi SK, Mariam Z. Artificial intelligence in drug development: reshaping the therapeutic landscape. Ther Adv Drug Saf. 2025;16:20420986251321704. doi: 10.1177/20420986251321704. DOI: https://doi.org/10.1177/20420986251321704
Ranchon F, Chanoine S, Lambert-Lacroix S, Bosson JL, Moreau-Gaudry A, Bedouch P. Development of artificial intelligence powered apps and tools for clinical pharmacy services: A systematic review. Int J Med Inform. 2023;172:104983. doi: 10.1016/j.ijmedinf.2022.104983. DOI: https://doi.org/10.1016/j.ijmedinf.2022.104983
González-Pérez Y, et al. Approaching artificial intelligence to Hospital Pharmacy. Farm Hosp. 2024;48 Suppl 1:S35-S44. doi: 10.1016/j.farma.2024.02.007. DOI: https://doi.org/10.1016/j.farma.2024.02.007
Chalasani SH, Syed J, Ramesh M, et al. Artificial intelligence in the field of pharmacy practice: A literature review. Explor Res Clin Soc Pharm. 2023;12:100346. doi: 10.1016/j.rcsop.2023.100346. DOI: https://doi.org/10.1016/j.rcsop.2023.100346
Lin AC, Lee J, Gabriel MK, et al. The Pharmacy 5.0 framework: A new paradigm to accelerate innovation for large-scale personalized pharmacy care. Am J Health Syst Pharm. 2024;81:e141-e147. doi: 10.1093/ajhp/zxad212. DOI: https://doi.org/10.1093/ajhp/zxad212
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Pedro Amariles, Jaime Alejandro Hincapié
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The articles, which are published in this journal, are subject to the following terms in relation to the rights of patrimonial or exploitation:
- The authors will keep their copyright and guarantee to the journal the right of first publication of their work, which will be distributed with a Creative Commons BY-NC-SA 4.0 license that allows third parties to reuse the work whenever its author, quote the original source and do not make commercial use of it.
b. The authors may adopt other non-exclusive licensing agreements for the distribution of the published version of the work (e.g., deposit it in an institutional telematic file or publish it in a monographic volume) provided that the original source of its publication is indicated.
c. Authors are allowed and advised to disseminate their work through the Internet (e.g. in institutional repositories or on their website) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).
